Literature DB >> 33778691

Critical Changes in the Staging of Head and Neck Cancer.

Christine M Glastonbury1.   

Abstract

The many changes made to the head and neck (HN) chapters of the eighth edition of the American Joint Committee on Cancer (AJCC) and Union for International Cancer Control (UICC) cancer staging manuals have resulted in confusion from clinicians and radiologists. These changes have even raised concerns for validity. In prior staging manual updates, the changes made largely provided simplification of more complex staging details. The current eighth edition of the AJCC/UICC staging manuals introduced greater granularity to HN tumor staging. This reflects the current understanding of pathophysiology of these cancers and is necessary to create a more accurate prognosis for these patients. The most commonly encountered example of manual changes is the separate staging of viral-associated oropharyngeal squamous cell carcinoma from tobacco and alcohol use-associated squamous cell carcinoma. While anatomic imaging is critical for HN cancer staging, and frequently outweighs clinical examination, some changes to staging make it impossible for a stage to be assigned until surgical resection is performed. In all, the AJCC/UICC eighth edition changes, the impact on radiologists, and the rationale behind the changes will be discussed. Additionally, opportunities for radiologists to contribute to research that may influence the next edition of AJCC/UICC cancer staging manuals will be proposed. Keywords: Head/Neck, Oncology, Pharynx, Staging © RSNA, 2020. 2020 by the Radiological Society of North America, Inc.

Entities:  

Year:  2020        PMID: 33778691      PMCID: PMC7983704          DOI: 10.1148/rycan.2019190022

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN: 2638-616X


  33 in total

1.  Radiographic extracapsular extension and treatment outcomes in locally advanced oropharyngeal carcinoma.

Authors:  Benjamin H Kann; Michael Buckstein; Todd J Carpenter; Richard Bakst; Krzysztof Misiukiewicz; Eric Genden; Marshall Posner; Lale Kostakoglu; Peter Som; Vishal Gupta
Journal:  Head Neck       Date:  2014-01-13       Impact factor: 3.147

2.  p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.

Authors:  Christine H Chung; Qiang Zhang; Christina S Kong; Jonathan Harris; Elana J Fertig; Paul M Harari; Dian Wang; Kevin P Redmond; George Shenouda; Andy Trotti; David Raben; Maura L Gillison; Richard C Jordan; Quynh-Thu Le
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

3.  Soft tissue metastasis in p16-positive oropharynx carcinoma: Prevalence and association with distant metastasis.

Authors:  Parul Sinha; James S Lewis; Dorina Kallogjeri; Brian Nussenbaum; Bruce H Haughey
Journal:  Oral Oncol       Date:  2015-05-29       Impact factor: 5.337

4.  Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma.

Authors:  Volkert B Wreesmann; Nora Katabi; Frank L Palmer; Pablo H Montero; Jocelyn C Migliacci; Mithat Gönen; Diane Carlson; Ian Ganly; Jatin P Shah; Ronald Ghossein; Snehal G Patel
Journal:  Head Neck       Date:  2015-10-30       Impact factor: 3.147

5.  A comparison of published head and neck stage groupings in carcinomas of the tonsillar region.

Authors:  P A Groome; K M Schulze; W J Mackillop; B Grice; C Goh; B J Cummings; S F Hall; F F Liu; D Payne; D M Rothwell; J N Waldron; P R Warde; B O'Sullivan
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

6.  p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency.

Authors:  Adel K El-Naggar; William H Westra
Journal:  Head Neck       Date:  2011-12-16       Impact factor: 3.147

7.  Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site.

Authors:  Jason W Chan; Iwei Yeh; Ivan H El-Sayed; Alain P Algazi; Christine M Glastonbury; Patrick K Ha; Sue S Yom; Annemieke van Zante
Journal:  Head Neck       Date:  2019-01-11       Impact factor: 3.147

8.  Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.

Authors:  Astrid Billfalk-Kelly; Eugene Yu; Jie Su; Brian O'Sullivan; John Waldron; Jolie Ringash; Eric Bartlett; Bayardo Perez-Ordonez; Ilan Weinreb; Andrew Bayley; Scott V Bratman; John Cho; Meredith Giuliani; Andrew Hope; Ali Hosni; John Kim; Aaron R Hansen; John de Almeida; Li Tong; Wei Xu; Shao Hui Huang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-04-04       Impact factor: 7.038

9.  Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy.

Authors:  Su Jung Shim; Jihye Cha; Woong Sub Koom; Gwi Eon Kim; Chang Geol Lee; Eun Chang Choi; Ki Chang Keum
Journal:  Radiat Oncol       Date:  2010-05-27       Impact factor: 3.481

10.  Changes in Unknown Primary Squamous Cell Carcinoma of the Head and Neck at Initial Presentation in the Era of Human Papillomavirus.

Authors:  Kevin Motz; Jesse R Qualliotine; Eleni Rettig; Jeremy D Richmon; David W Eisele; Carole Fakhry
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-03       Impact factor: 6.223

View more
  2 in total

1.  Multimodal Dimension Reduction and Subtype Classification of Head and Neck Squamous Cell Tumors.

Authors:  Jonathan E Bard; Norma J Nowak; Michael J Buck; Satrajit Sinha
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

2.  Muscle and adipose tissue segmentations at the third cervical vertebral level in patients with head and neck cancer.

Authors:  Kareem A Wahid; Brennan Olson; Rishab Jain; Aaron J Grossberg; Dina El-Habashy; Cem Dede; Vivian Salama; Moamen Abobakr; Abdallah S R Mohamed; Renjie He; Joel Jaskari; Jaakko Sahlsten; Kimmo Kaski; Clifton D Fuller; Mohamed A Naser
Journal:  Sci Data       Date:  2022-08-02       Impact factor: 8.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.